Related Experiment Videos
Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells
V Bhattacharya1, P A McSweeney, Q Shi
1The Hope Heart Institute and Providence Seattle Medical Center, the Fred Hutchinson Cancer Research Center, and the Departments of Surgery and Medicine, University of Washington School of Medicine, Seattle, WA.
Blood
|January 11, 2000
Summary
Seeding vascular grafts with CD34(+) progenitor cells from bone marrow significantly enhanced endothelialization in a canine model. This suggests a promising therapeutic approach for improving vascular graft healing and integration.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Vascular Surgery
Background:
- Bone marrow contains CD34(+) progenitor cells capable of differentiating into endothelial cells.
- Previous in vitro studies indicated the potential of CD34(+) cells in endothelialization.
- Accelerated endothelialization is crucial for successful vascular graft healing.
Purpose of the Study:
- To investigate the efficacy of CD34(+) progenitor cells in enhancing vascular graft healing.
- To evaluate the impact of CD34(+) cell seeding on endothelialization in a canine model.
- To determine the therapeutic potential of CD34(+) cells for vascular graft applications.
Main Methods:
- Composite vascular grafts with a polyethylene terephthalate (PET) core were implanted in canine descending thoracic aortas.
- CD34(+) progenitor cells were enriched from autologous bone marrow using immunomagnetic bead separation.
- Study grafts were seeded with CD34(+) cells mixed with venous blood; control grafts received venous blood only.
Main Results:
- Grafts seeded with CD34(+) cells showed significantly higher endothelialization (92% +/- 3.4%) compared to controls (26.6% +/- 7.6%).
- Increased microvessel formation was observed in the neointima, graft wall, and external areas of seeded grafts.
- Histological staining confirmed enhanced graft healing and integration in the CD34(+) cell-seeded group.
Conclusions:
- CD34(+) progenitor cell seeding significantly enhances vascular graft endothelialization in vivo.
- This method offers a promising strategy for improving the patency and integration of vascular grafts.
- The findings support the practical therapeutic application of CD34(+) cells in vascular surgery.